BioSpace News Archive

Marinus Pharmaceuticals, Inc. announced that management will present at the Morgan Stanley Virtual Global Healthcare Conference, H.C Wainwright Virtual Global Investment Conference and Cantor Virtual Global Healthcare Conference during the week of September 14.

San Diego, Calif.-based biotech company Diomics Corp. is aiming to nose out the novel coronavirus ahead of vaccines by using nanosized biopolymer beads to deliver monoclonal antibody protection against COVID-19 via an easy-to-administer nasal spray.

Nextech Systems, LLC, a leading provider of healthcare technology solutions for specialty providers, today announced a new glaucoma flowsheet and other feature enhancements for its ophthalmology-specific EHR, IntelleChartPRO.

The Alzheimer’s Association announced that it has been selected by the Centers for Disease Control and Prevention as the BOLD Public Health Center of Excellence on Dementia Risk Reduction.

A novel study in AACC’s Clinical Chemistry journal shows that a new test for SARS-CoV-2 viral proteins known as antigens could determine which COVID-19 patients are most likely to become critically ill.

LIPAC Oncology LLC today announced the successful completion of a Phase 2A marker lesion clinical trial designed to predict long-term (two-year) recurrence free survival rates in patients with low-grade highly recurrent Non-Muscle Invasive Bladder Cancer (NMIBC) treated with LiPax (paclitaxel).

A 12-year-long collaboration with Canon Medical Research USA, Canon Medical Systems Japan and Southern Nevada outpatient radiology leader Steinberg Diagnostic Medical Imaging (SDMI) has resulted in the development of 3 PET Scanners, each generation more advanced than the last.

“Treatment of the first patient is a significant milestone for Lonza and demonstrates the Cocoon’s capability to manufacture patient-scale cellular immunotherapies in a cGMP setting for clinical use. Moreover, this project has demonstrated the feasibility and attractiveness of moving open processes into the automated and functionally closed Cocoon Platform, and the ability to enable decentralized manufacturing at point-of-care.

Aquavit Pharmaceuticals, Inc. (“Aquavit”) won a default judgement against counterfeiter in the United States District Court for the Southern District of New York in a civil action against Global Medi Products, a South Korean company.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced the appointment of Jonathan Biller to the role of chief financial officer, head of legal and corporate affairs effective September 11, 2020.